Publicacións en colaboración con investigadores/as de GlaxoSmithKline (Spain) (1)

2006

  1. Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain

    PharmacoEconomics, Vol. 24, Núm. SUPPL. 1, pp. 49-59